Alembic Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,847.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.52 per cent from ₹1,876.31 crore. This corresponds to a year-on-year *(YoY) growth of 4.41 per cent.
Operating Profit
Operating Profit stands at ₹203.16 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.55 per cent from ₹249.43 crore. This corresponds to a year-on-year *(YoY) decline of 25.11 per cent.
PBDT
PBDT stands at ₹207.21 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 14.24 per cent from ₹241.62 crore. This corresponds to a year-on-year *(YoY) decline of 20.59 per cent.
Profit Before Tax
Profit Before Tax stands at ₹118.62 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 26.55 per cent from ₹161.50 crore. This corresponds to a year-on-year *(YoY) decline of 38.20 per cent.
Net Profit
Net Profit stands at ₹201.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 52.73 per cent from ₹131.95 crore. This represents a 28.67 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Alembic Pharmaceuticals Ltd News
Alembic Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Alembic Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Alembic Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Alembic Pharmaceuticals Ltd Financial Reports
Alembic Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Alembic Pharma | 0.27% | 2.52% | -5.20% | 4.32% | -16.31% | -25.53% |
| Natco Pharma | -2.75% | -4.24% | -22.57% | -10.83% | -0.57% | 3.50% |
| Jubilant Pharmo | -0.14% | -1.82% | -0.79% | 18.59% | -6.25% | -14.86% |
| Caplin Point Lab | 0.83% | 1.76% | 8.85% | 21.78% | 5.41% | -0.92% |
| Concord Biotech | -2.19% | 14.15% | 1.13% | 2.83% | -11.48% | -39.87% |
| Alivus Life | -0.10% | -1.66% | -8.05% | 12.02% | 19.59% | 1.61% |
| Viyash Scientific | 2.39% | 1.86% | 15.04% | 33.73% | 30.41% | 34.71% |
Company Info
Company Information
Chairman and MD & CEO : Chirayu R Amin
Independent Director : Pranav N Parikh
Independent Director : K G Ramanathan
Independent Director : Paresh Saraiya
Director & CFO : Rajkumar Baheti
Independent Director : Milin Mehta
Managing Director : Pranav Amin
Managing Director : Shaunak Amin
Independent Director : Archana Hingorani
Company Secretary : Charandeep Singh Saluja